Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sama Adnan"'
Autor:
Sama Adnan, R Keith Reeves, Jacqueline Gillis, Fay E Wong, Yi Yu, Jeremy V Camp, Qingsheng Li, Michelle Connole, Yuan Li, Michael Piatak, Jeffrey D Lifson, Wenjun Li, Brandon F Keele, Pamela A Kozlowski, Ronald C Desrosiers, Ashley T Haase, R Paul Johnson
Publikováno v:
PLoS Pathogens, Vol 12, Iss 12, p e1006104 (2016)
Defining the correlates of immune protection conferred by SIVΔnef, the most effective vaccine against SIV challenge, could enable the design of a protective vaccine against HIV infection. Here we provide a comprehensive assessment of immune response
Externí odkaz:
https://doaj.org/article/06b3afcb40fe45a695d045607398c274
Autor:
James M Billingsley, Premeela A Rajakumar, Michelle A Connole, Nadine C Salisch, Sama Adnan, Yury V Kuzmichev, Henoch S Hong, R Keith Reeves, Hyung-joo Kang, Wenjun Li, Qingsheng Li, Ashley T Haase, R Paul Johnson
Publikováno v:
PLoS Pathogens, Vol 11, Iss 3, p e1004740 (2015)
The onset of protective immunity against pathogenic SIV challenge in SIVΔnef-vaccinated macaques is delayed for 15-20 weeks, a process that is related to qualitative changes in CD8+ T cell responses induced by SIVΔnef. As a novel approach to charac
Externí odkaz:
https://doaj.org/article/5fbe518dbfca4582888711391c84f7e3
Autor:
Sama Adnan, Arnaud D Colantonio, Yi Yu, Jacqueline Gillis, Fay E Wong, Ericka A Becker, Michael Piatak, R Keith Reeves, Jeffrey D Lifson, Shelby L O'Connor, R Paul Johnson
Publikováno v:
PLoS Pathogens, Vol 11, Iss 2, p e1004633 (2015)
The live attenuated simian immunodeficiency virus (LASIV) vaccine SIVΔnef is one of the most effective vaccines in inducing protection against wild-type lentiviral challenge, yet little is known about the mechanisms underlying its remarkable protect
Externí odkaz:
https://doaj.org/article/8fd943c4d1fd42498617beb0f66b54b1
Autor:
Sanjeet Singh Dadwal, Jo-Anne H. Young, Michael W Schuster, Jean Adel Yared, Doug Myers, Michelle Matzko, Sama Adnan, Sarah Gilmore, Spyridoula Vasileiou, Ann M. Leen, Joshua A. Hill, Rajat Bansal
Publikováno v:
Transplantation and Cellular Therapy. 29:S65-S66
Autor:
Sanjeet S Dadwal, Jo-Anne H. Young, Michael W. Schuster, Jean A. Yared, Gary Douglas Myers, Michelle Matzko, Sama Adnan, Joshua A. Hill, Rajat Bansal
Publikováno v:
Blood. 140:878-879
Autor:
R. Keith Reeves, Qingsheng Li, Michelle Connole, Yi Yu, R. Paul Johnson, Jeremy V. Camp, Pamela A. Kozlowski, Wenjun Li, Jeffrey D. Lifson, Yuan Li, Fay E. Wong, Michael Piatak, Jacqueline Gillis, Brandon F. Keele, Sama Adnan, Ashley T. Haase, Ronald C. Desrosiers
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 12, Iss 12, p e1006104 (2016)
PLoS Pathogens, Vol 12, Iss 12, p e1006104 (2016)
Defining the correlates of immune protection conferred by SIVΔnef, the most effective vaccine against SIV challenge, could enable the design of a protective vaccine against HIV infection. Here we provide a comprehensive assessment of immune response
Autor:
Nadine C. Salisch, R. Keith Reeves, Hyung joo Kang, Sama Adnan, R. Paul Johnson, Henoch S. Hong, Yury V. Kuzmichev, Qingsheng Li, James M. Billingsley, Premeela A. Rajakumar, Michelle Connole, Ashley T. Haase, Wenjun Li
Publikováno v:
PLoS Pathogens, Vol 11, Iss 3, p e1004740 (2015)
PLoS Pathogens
PLoS Pathogens
The onset of protective immunity against pathogenic SIV challenge in SIVΔnef-vaccinated macaques is delayed for 15-20 weeks, a process that is related to qualitative changes in CD8+ T cell responses induced by SIVΔnef. As a novel approach to charac
Autor:
Shelby L. O’Connor, Arnaud D. Colantonio, Fay E. Wong, Sama Adnan, Yi Yu, Ericka A. Becker, Michael Piatak, Jeffrey D. Lifson, Jacqueline Gillis, R. Paul Johnson, R. Keith Reeves
Publikováno v:
PLoS Pathogens, Vol 11, Iss 2, p e1004633 (2015)
PLoS Pathogens
PLoS Pathogens
The live attenuated simian immunodeficiency virus (LASIV) vaccine SIVΔnef is one of the most effective vaccines in inducing protection against wild-type lentiviral challenge, yet little is known about the mechanisms underlying its remarkable protect
Autor:
Alexander T. Bean, Sama Adnan, David I. Watkins, David B. Allison, Chungwon Chung, Wonhee Lee, Otto O. Yang, Anna K. Jonas, Nancy A. Wilson, John T. Loffredo, Akihiko Hoji, Eva G. Rakasz, Sean P. Spencer, Jonah B. Sacha, Benjamin J. Burwitz, Jeffrey D. Lifson, Thomas C. Friedrich, Jason J. Stephany
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 178(5)
CD8+ T cells are a key focus of vaccine development efforts for HIV. However, there is no clear consensus as to which of the nine HIV proteins should be used for vaccination. The early proteins Tat, Rev, and Nef may be better CD8+ T cell targets than
Autor:
Christian Brander, Arumugam Balamurugan, Ayub Ali, Alicja Trocha, Michael S. Bennett, Hwee L. Ng, Sama Adnan, Otto O. Yang
Publikováno v:
Blood. 108(10)
HIV-1 Nef and HIV-1–specific cytotoxic T lymphocytes (CTLs) have important and opposing roles in the immunopathogenesis of HIV-1 infection. Nef-mediated down-modulation of HLA class I on infected cells can confer resistance to CTL clearance, but th